Providing new pathways for neuroscience research and education
Payton Dupuis finds new scientific interests and career opportunities through MIT summer research program in biology.
Design prevents buildup of scar tissue around medical implants
A new device, which doesn’t rely on immunosuppressing drugs, may assist efforts to develop an artificial pancreas to treat diabetes.
Amy Moran-Thomas receives the Edgerton Faculty Achievement Award
The MIT anthropologist is recognized for interdisciplinary work on health, climate, and equity.
On planetary change and human health
MIT anthropologist Amy Moran-Thomas reflects on the deep connection between planetary and human well-being.
“Living drug factories” might treat diabetes and other diseases
Chemical engineers have developed a way to protect transplanted drug-producing cells from immune system rejection.
Mathematical model could lead to better treatment for diabetes
A new model can predict which types of glucose-responsive insulin will work in humans and animals.
Health care innovators strive to make a difference
A week of learning with MIT Bootcamps sparked ideas that Jal Panchal and Maria Hahn are taking forward to solve problems in health care.
Hydration sensor could improve dialysis
Noninvasive device could benefit patients with kidney disease, congestive heart failure, or dehydration.
A better way to encapsulate islet cells for diabetes treatment
Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
Chemists discover structure of glucagon fibrils
Study may be a step toward shelf-stable versions of the hormone, which is used to control diabetes.
Oxygen-tracking method could improve diabetes treatment
Measurements could help scientists develop better designs for a bioartificial pancreas.
“Living drug factories” may one day replace injections
Startup develops implantable, encased cells that live in the body and secrete insulin and other therapeutics.
Implantable islet cells come with their own oxygen supply
Device could help insulin-producing cells live longer after transplant and improve treatment of type 1 diabetes.
![“[Glucose-responsive insulin] has been a longstanding goal of the diabetes field,” says professor Michael Strano. “If done correctly, you could make it so that diabetics could take an occasional dose and never have to worry about their blood sugar.”](/sites/default/files/styles/term_page__news_article/public/images/201709/MIT-Glucose-Insulin.jpg?itok=DxQhQ2rC)
Model predicts performance of glucose-responsive insulin
Engineered insulin that can be activated by high blood sugar could improve diabetics’ quality of life.
Smart mat detects early warning signs of foot ulcers
Conceived at an MIT hackathon, system could reduce amputations, cut medical costs for diabetics.